This topic contains a solution. Click here to go to the answer

Author Question: If an owner of a company that produces a lot of waste wants to be able to keep polluting, what, ... (Read 139 times)

rosent76

  • Hero Member
  • *****
  • Posts: 516
If an owner of a company that produces a lot of waste wants to be able to keep polluting, what, according to the text, is that owners best strategy?
 
  A) Lobby and otherwise use the political system to ensure regulations are lax
  B) Realize the pollution is too damaging, take responsibility for causing the pollution, and pay for the cleanup.
  C) Do nothing.
  D) Only pollute at night when fewer people will notice

Question 2

The sharing of knowledge by members of a society exists in a(n) __________.
 
  A) environmental justice league
  B) biosphere
  C) culture
  D) ecosystem



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

dpost18

  • Sr. Member
  • ****
  • Posts: 345
Answer to Question 1

Answer: A

Answer to Question 2

Answer: C




rosent76

  • Member
  • Posts: 516
Reply 2 on: Jul 2, 2018
Thanks for the timely response, appreciate it


AmberC1996

  • Member
  • Posts: 317
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

For pediatric patients, intravenous fluids are the most commonly cited products involved in medication errors that are reported to the USP.

Did you know?

It is difficult to obtain enough calcium without consuming milk or other dairy foods.

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

Lower drug doses for elderly patients should be used first, with titrations of the dose as tolerated to prevent unwanted drug-related pharmacodynamic effects.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library